Cargando…

A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic

OBJECTIVE: The recent hydroxychloroquine (HCQ) shortage due to use in coronavirus disease 2019 (COVID‐19) has forced some rheumatic disease patients to choose between continuing their current dose of HCQ but exhaust their supply early or ration it in order to prolong its use. Blood HCQ concentration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheetz, Marc H., Konig, Maximilian F., Robinson, Philip C., Sparks, Jeffrey A., Kim, Alfred H.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437131/ https://www.ncbi.nlm.nih.gov/pubmed/32725866 http://dx.doi.org/10.1002/acr2.11164

Ejemplares similares

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages
por: McLaughlin, Milena M., et al.
Publicado: (2014)

Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
por: Egeli, Bugra Han, et al.
Publicado: (2021)

Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease
por: Robinson, Philip C., et al.
Publicado: (2021)

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
por: Morrisette, Taylor, et al.
Publicado: (2020)

Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
por: Paik, Julie J., et al.
Publicado: (2022)

Effects on Patient Care Caused by Drug Shortages: A Survey
por: McLaughlin, Milena, et al.
Publicado: (2013)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
por: Nirk, Eliise Laura, et al.
Publicado: (2020)

Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management
por: McLaughlin, Milena M., et al.
Publicado: (2017)

Hydroxychloroquine: small effects in mild disease
por: Levantovsky, Rachel, et al.
Publicado: (2020)

Anomalous supply shortages from dynamic pricing in on-demand mobility
por: Schröder, Malte, et al.
Publicado: (2020)

Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
por: Ison, Michael G., et al.
Publicado: (2021)

Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination
por: Whelan, Mary Grace, et al.
Publicado: (2023)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
por: Weiss, Johanna, et al.
Publicado: (2020)

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs
por: Barber, Katie E., et al.
Publicado: (2016)

The Shortage of Husbands
por: Walker, William H.
Publicado: (1918)

The Shortage of Doctors
por: Fitzgerald, Gerald H.
Publicado: (1918)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

The Staffing Shortage Pandemic
por: Chervoni-Knapp, Tanya
Publicado: (2022)

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers
por: de Reus, Y. A., et al.
Publicado: (2022)

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
por: dos Reis Neto, Edgard Torres, et al.
Publicado: (2020)

Comment on: incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine: reply
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Novel manufacturing of simple masks in response to international shortages: Bacterial and particulate filtration efficiency testing
por: Bayersdorfer, Jennifer, et al.
Publicado: (2020)

1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients
por: Liu, Jiajun, et al.
Publicado: (2019)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Committees and the Shortage of Resident Medical Officers : Is There Shortage?
Publicado: (1914)

Teaching focused echocardiography for rheumatic heart disease screening
por: Engelman, Daniel, et al.
Publicado: (2015)

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
por: Alvarez, Jean Claude, et al.
Publicado: (2022)

Rapid Adoption of Telemedicine in Rheumatology Care During the COVID‐19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees
por: Yeoh, Su‐Ann, et al.
Publicado: (2021)

One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage
por: Tonetti, Tommaso, et al.
Publicado: (2020)

Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
por: Grainger, Rebecca, et al.
Publicado: (2022)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebr03l15fvjjr94q80lb9sicrv